How Does Enhabit Home Health & Hospice Company Work?

Enhabit provides skilled nursing, physical, occupational, and speech therapy, along with medical social services and hospice care. These Enhabit services are tailored to individuals recovering from illness, managing chronic conditions, or requiring end-of-life support.

The company meticulously structures its operational processes for high-quality in-home delivery. Advanced technology, including AI, is leveraged to reduce documentation, allowing clinical teams more time for direct Enhabit patient care.

An updated case management model and consolidated admissions departments have improved response times and conversion rates. In Q1 2025, Enhabit achieved a 79% referral-to-admission rate for hospice care.

With over 370 locations across 34 states, Enhabit ensures widespread access to its Enhabit healthcare services. Their 30-day home health hospital readmission rate is 20.0% better than the national average.

Enhabit has proactively renegotiated payer contracts to secure better pricing and transition towards more episodic arrangements. A significant achievement was the re-establishment of a national contract with UnitedHealthcare in December 2024.

The company has implemented cost control initiatives, resulting in a 2.4% decrease in home health cost per patient day in Q1 2025. Further cost savings of $1.5 million are anticipated for the remainder of 2025 through the outsourcing of coding resources.

Enhabit strategically closed or consolidated seven branches in 2024 and plans for four more closures by the end of Q2 2025 to enhance efficiency. Simultaneously, the company is prioritizing de novo development, opening new locations to expand its reach.

Enhabit leverages technology, including AI, to improve operational efficiency and clinical productivity. The company's commitment to quality care is demonstrated by a 30-day home health hospital readmission rate that is 20.0% better than the national average.

Enhabit Home Health & Hospice holds a significant market share, ranking as the fourth-largest provider of home health services and a prominent player in hospice care nationwide. Its extensive network of 255 home health and 115 hospice locations across 34 states underscores its broad reach and established presence in the healthcare sector.

The company navigates several industry-wide challenges, including potential regulatory shifts in Medicare payment models and evolving antitrust regulations. Staffing shortages, a persistent issue in healthcare, are being addressed through new recruitment and retention strategies. Intense competition within the fragmented home health and hospice market, alongside the risk of technological disruption, also presents ongoing concerns for Enhabit.

Enhabit's strategic priorities for 2025 focus on growth, financial stability, quality of care, and its workforce. The company anticipates an increase in patient census for both home health and hospice services, supported by investments in technology and workforce development. A key element of its expansion plan involves a de novo strategy, targeting approximately 10 new sites annually, with a preference for hospice locations.

The company has actively strengthened its financial position, reducing bank debt by $45 million since Q1 2024 and improving its net debt to adjusted EBITDA ratio to 4.3x by Q2 2025. For the full year 2025, Enhabit projects net service revenue between $1,060 million and $1,073 million, with Adjusted EBITDA expected to range from $104 million to $108 million.